In the 1980s, only 4% of new drugs approved by the FDA were cancer treatments. But since 2010, cancer drugs have claimed 27% of new approvals—a share that doubled over the previous decade—according to a new report from the Tufts Center for the Study of Drug Development.
This seems like a silly question. Of course it is not enough. But physicians today feel the pressure to see more and more patients, faster and faster due to increasing financial pressures. Fred N. Pelzman, MD has a very interesting perspective on this issue I wanted to share. In his September 1 Medpage article "20 Minutes Enough for an Office Visit? Yeah, Right. You've got a list you want to discuss? So do I", Dr. Pelzman shares his view on the subject. Click here to read